- Home
- DHIL vs CGC Comparison
DHIL vs CGC Comparison
Compare DHIL & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHIL
- CGC
- Stock Information
- Founded
- DHIL 1990
- CGC 2009
- Country
- DHIL United States
- CGC Canada
- Employees
- DHIL N/A
- CGC N/A
- Industry
- DHIL Investment Managers
- CGC Pharmaceuticals and Biotechnology
- Sector
- DHIL Finance
- CGC Health Care
- Exchange
- DHIL Nasdaq
- CGC Nasdaq
- Market Cap
- DHIL 424.8M
- CGC 446.7M
- IPO Year
- DHIL 1995
- CGC N/A
- Fundamental
- Price
- DHIL $169.65
- CGC $3.86
- Analyst Decision
- DHIL
- CGC Sell
- Analyst Count
- DHIL 0
- CGC 1
- Target Price
- DHIL N/A
- CGC $2.00
- AVG Volume (30 Days)
- DHIL 14.3K
- CGC 7.3M
- Earning Date
- DHIL 11-04-2024
- CGC 11-08-2024
- Dividend Yield
- DHIL 3.53%
- CGC N/A
- EPS Growth
- DHIL 21.33
- CGC N/A
- EPS
- DHIL 17.67
- CGC N/A
- Revenue
- DHIL $145,795,446.00
- CGC $207,628,706.00
- Revenue This Year
- DHIL N/A
- CGC N/A
- Revenue Next Year
- DHIL N/A
- CGC $7.76
- P/E Ratio
- DHIL $9.60
- CGC N/A
- Revenue Growth
- DHIL 5.76
- CGC N/A
- 52 Week Low
- DHIL $135.44
- CGC $2.76
- 52 Week High
- DHIL $173.98
- CGC $14.92
- Technical
- Relative Strength Index (RSI)
- DHIL 61.47
- CGC 40.32
- Support Level
- DHIL $167.89
- CGC $3.75
- Resistance Level
- DHIL $171.70
- CGC $3.88
- Average True Range (ATR)
- DHIL 2.72
- CGC 0.35
- MACD
- DHIL 0.51
- CGC -0.07
- Stochastic Oscillator
- DHIL 83.79
- CGC 10.60
About DHIL Diamond Hill Investment Group Inc.
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.